Skip to main content
FinSpry Logo
FinSpry
BCAB logo
BCAB
(NASDAQ)
BioAtla, Inc.
$0.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

BioAtla (BCAB) Stock Price & Financial Analysis

BioAtla Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.12 - $0.14
52-Week High$1.43
52-Week Low$0.12
Open$0.12
Volume2.99M
Average Volume (3M)2.99M
Market Cap7.91M
Shares Outstanding58.75M
EV/EBITDA-0.09
50-Day MA$0.20
200-Day MA$0.49
52-Week Change-61.89%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About BioAtla

What is the current stock price for BCAB?

As of the latest trading session, BCAB stock trades at $0.13. The 52-week range is $0.12–$1.43, with a day range of $0.12–$0.14.

What is the P/E ratio for BCAB?

The P/E ratio (Price-to-Earnings) for BCAB is shown in the Key Statistics section. This valuation metric helps compare BioAtla, Inc. to industry peers.

Does BCAB pay dividends?

BioAtla does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for BCAB?

Analyst ratings and recommendations for BCAB are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of BCAB?

BioAtla's market capitalization is $7.9M, classifying it as a micro-cap company. BioAtla operates in the Healthcare sector within the Biotechnology industry.